Amunix Appoints Anne Keane as Senior Vice President of Regulatory and Quality
May 27, 2020 07:00 ET
|
Amunix Pharmaceuticals, Inc.
MOUNTAIN VIEW, Calif., May 27, 2020 (GLOBE NEWSWIRE) -- Amunix Pharmaceuticals, Inc. (“Amunix”), a biopharmaceutical company focused on developing prodrugs to bring the promise of potent...
CytomX Therapeutics Appoints Halley E. Gilbert to Board of Directors
April 28, 2020 16:05 ET
|
CytomX Therapeutics Inc.
SOUTH SAN FRANCISCO, Calif., April 28, 2020 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of...
Halley E. Gilbert Appointed to Arcutis Board of Directors
April 27, 2020 08:30 ET
|
Arcutis Biotherapeutics, Inc.
WESTLAKE VILLAGE, Calif., April 27, 2020 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments...
Novome Biotechnologies Raises $33 Million Series A Financing and Appoints Blake Wise as Chief Executive Officer
January 07, 2020 10:00 ET
|
Novome Technologies, Inc.
− Proceeds to advance lead hyperoxaluria program through Phase 1 clinical proof-of-concept − − Financing led by DCVC Bio and included 5AM Ventures and Alta Partners − SOUTH SAN FRANCISCO, Calif.,...
Worldwide Antibiotic Resistance Markets, 2020-2024: Therapeutics by Pathogen & Therapy Type
October 30, 2019 09:34 ET
|
Research and Markets
Dublin, Oct. 30, 2019 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics By Pathogen and Therapy Type 2020 To 2024" report has been added to ResearchAndMarkets.com's ...
Applied Molecular Transport Appoints Veteran Biopharmaceutical Executive, Liz Bhatt, to Role as Chief Business and Strategy Officer
October 10, 2019 08:00 ET
|
Applied Molecular Transport
SOUTH SAN FRANCISCO, Calif., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Applied Molecular Transport (AMT), a clinical-stage biopharmaceutical company, today announced the appointment of Liz Bhatt to the...
Global Antibiotic Resistance Market is Expected to Reach USD 13.16 Billion by 2025 : Fior Markets
August 08, 2019 03:15 ET
|
Fior Markets
New Jersey, NJ, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Increasing resistance against antibiotics, increasing burden of antibiotic-resistant infections, growing demand for generic drugs from emerging...
CymaBay Reports Second Quarter 2019 Financial Results and Provides Corporate Update
August 07, 2019 16:10 ET
|
CymaBay Therapeutics, Inc.
NEWARK, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic...
CymaBay Therapeutics Strengthens Management Team with Appointment of Janet Dorling as Chief Commercial Officer
August 05, 2019 08:00 ET
|
CymaBay Therapeutics, Inc.
NEWARK, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on developing and providing access to innovative therapies for...
Global Aminoglycosides Market is Expected to Reach USD 2.78 Billion by 2026
July 08, 2019 07:06 ET
|
Fior Markets
New Jersey, NJ, July 08, 2019 (GLOBE NEWSWIRE) -- Fior Markets launched a study titled “Aminoglycosides Market by Product (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Other...